在自身免疫性疾病中准新生儿Fc受体:管道和进展
Torleif Tollefsrud Gjølberg1,2,3,4, Simone Mester5,6,7,8, Gaia Calamera5
1Authera AS, 0349, Oslo, Norway. torleif@authera.bio.
概括
针对新生儿Fc受体 (FcRn) 提供了一种有前途的新策略,用于治疗由免疫球蛋白G (IgG) 自体抗体驱动的自身免疫性疾病. 这种方法旨在消除致病性IgG,为各种自身免疫性疾病提供希望.
科学领域:
- 免疫学 免疫学 免疫学
- 这是一种自身免疫力.
- 药理学 药理学是指药理学的学科.
背景情况:
- 自免疫性疾病很常见,不成比例地影响女性,并以自我反应性抗体为特征.
- 致病性免疫球蛋白G (IgG) 自抗体通过攻击健康细胞驱动疾病,需要针对性的治疗.
- 新生儿Fc受体 (FcRn) 通过防止其降解来调节IgG和专蛋白水平.
研究的目的:
- 审查新生儿Fc受体 (FcRn) 在调节IgG自身抗体中的作用.
- 探索FcRn向策略用于治疗免疫球蛋白G驱动的自身免疫性疾病.
- 讨论FcRn抗剂的临床进展和未来发展方向.
主要方法:
- 对FcRn生物学及其在自身免疫性疾病中的作用的现有文献的综述.
- 对FcRn抗剂的临床试验数据的分析.
- 检查FcRn向剂的结构设计和治疗景观.
主要成果:
- FcRn对抗性在不同病理的各种自身免疫疾病中表现出有效性.
- 第一个FcRn抗剂已经获得批准,许多下一代分子正在开发中.
- 针对FcRn的策略显示出患有流行和罕见自身免疫性疾病的潜力.
结论:
- FcRn对抗剂在治疗IgG介导的自身免疫性疾病方面取得了重大进展.
- 这种治疗类型为治疗选择有限或不存在的患者提供了新的希望.
- 目前正在探索FcRn向原理,以用于超越自身免疫的更广泛的治疗应用.
相关概念视频
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...